BITWISE DESIGNS, INC. – Trademark Portfolio
Entity Type: 03
BITWISE DESIGNS, INC. holds 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 13 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DOCSTAR. The owner is based in SCHENECTADY, NY.
ROTTERDAM INDUSTRIAL PARK
BUILDING 50
SCHENECTADY, NY 12306
Showing of trademarks Trademarks
Trademark Classifications
BITWISE DESIGNS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does BITWISE DESIGNS, INC. have?
BITWISE DESIGNS, INC. has 25 U.S. trademarks filed with the USPTO. Of these, 1 registered, 21 abandoned, 3 cancelled.
What trademark classes does BITWISE DESIGNS, INC. file in?
BITWISE DESIGNS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are BITWISE DESIGNS, INC.'s most well-known trademarks?
BITWISE DESIGNS, INC.'s registered trademark portfolio includes well-known marks such as DOCSTAR. These are among 1 currently registered trademark in the portfolio.
What is BITWISE DESIGNS, INC.'s trademark registration success rate?
BITWISE DESIGNS, INC. has a 4% trademark registration rate, with 1 out of 25 resolved applications resulting in successful registration. Currently, 0 applications are pending review.